Great Basin Scientific Inc, Salt Lake City, recently released the GB550, an enhanced molecular diagnostic analyzer designed for faster test times and increased throughput, using streamlined design, an intuitive user interface, and a smaller footprint.
“Versatility, cost-effectiveness, and ease-of-use are our focus as we develop molecular diagnostic solutions to meet the needs of a wide variety of underserved hospitals and clinics,” says Ryan Ashton, cofounder and chief executive of Great Basin Scientific. “We’re pleased with the ongoing improvements we’ve made to our original instrument and how those efforts have informed the design of the GB550. Our customers will enjoy the smaller footprint, improved ease-of-use, and reduced test time, which we believe will make our system even more attractive to a wider variety of users that, in turn, will allow us to expand our footprint of installed sites. And, important to our business model, the ability for improved productivity per analyzer increases the company’s potential revenue per instrument by 35% to 40%.”
The GB550 will enable lab technicians to process tests in 75–90 minutes with the potential for some tests to be processed in less than an hour. The unit includes an integrated touchscreen and barcode scanner, which decreases the overall footprint and eliminates the need for external cables. The analyzer features a simplified software interface and will be compatible with all existing and future Great Basin tests and panels, including the company’s tests for toxigenic Clostridium difficile, Group B Streptococcus, as well as the newly cleared Shiga toxin direct test and Staph ID/R blood culture panel.
Great Basin expects to begin delivery of the new analyzer in the first half of 2017.
For more information, visit Great Basin Scientific.